Burjeel Holdings Feat Focus Newsletter-June 2024

MENACTRIMS Certification for Burjeel Multiple Sclerosis Center T he Burjeel Multiple Sclerosis Center has achieved the coveted MENACTRIMS certification. MENACTRIMS is an esteemed organization focusing on improving the care and research related to Multiple Sclerosis (MS), a complex autoimmune condition affecting the central nervous system. The center, located at Burjeel Hospital, Abu Dhabi, provides comprehensive and personalized care to MS patients.

Feat Focus Burjeel Holdings 32

Made with FlippingBook - professional solution for displaying marketing and sales documents online